Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein.
Mannik
M
M
Wener
M
M
D000906:Antibodies / Q000097:blood*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology* / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor / Q000276:immunology* / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000276:immunology / Q000627:therapeutic use; D012217:Rheumatoid Factor / Q000097:blood; D012680:Sensitivity and Specificity
D000906:Antibodies; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D012217:Rheumatoid Factor; D000068800:Etanercept